GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (MEX:TXG) » Definitions » 12-1 Month Momentum %

10x Genomics (MEX:TXG) 12-1 Month Momentum % : -46.52% (As of Oct. 31, 2024)


View and export this data going back to 2021. Start your Free Trial

What is 10x Genomics 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-10-31), 10x Genomics's 12-1 Month Momentum % is -46.52%.

The industry rank for 10x Genomics's 12-1 Month Momentum % or its related term are showing as below:

MEX:TXG's 12-1 Month Momentum % is ranked worse than
79.38% of 650 companies
in the Healthcare Providers & Services industry
Industry Median: -7.745 vs MEX:TXG: -46.52

Competitive Comparison of 10x Genomics's 12-1 Month Momentum %

For the Health Information Services subindustry, 10x Genomics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


10x Genomics's 12-1 Month Momentum % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where 10x Genomics's 12-1 Month Momentum % falls into.



10x Genomics  (MEX:TXG) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


10x Genomics  (MEX:TXG) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


10x Genomics 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of 10x Genomics's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


10x Genomics Business Description

Traded in Other Exchanges
Address
6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.